Table 3. Results of the regression analysis models built for the EQ-5D, EQ VAS and PDQ-39 separately.
Variables | Model 1 – EQ-5D | Model 2 – EQ VAS | Model 3 – PDQ-39 | Model 4 – HY† |
ln (total cost) | ln (total cost) | ln (total cost) | ln (total cost) | |
Age | −0.021 (0.013) | −0.027** (0.014) | −0.0168 (0.013) | −0.0338*** (0.012) |
Male | −0.325 (0.317) | −0.356 (0.328) | −0.274 (0.311) | −0.466* (0.277) |
Disease duration | 0.076*** (0.028) | 0.094*** (0.027) | 0.0885*** (0.027) | 0.0194 (0.032) |
EQ-5D | −1.530*** (0.561) | - | - | - |
EQ VAS | - | −0.023** (0.008) | - | - |
PDQ-39 | - | - | 0.0142 (0.011) | - |
HY I | - | - | - | −2.457*** (0.450) |
HY II | - | - | - | −0.366* (0.189) |
HY IV | - | - | - | −0.112 (0.115) |
Constant | 15.42*** (0.977) | 16.14*** (1.162) | 13.44*** (0.971) | 16.60*** (0.899) |
Observations | 95 | 91 | 101 | 99 |
F | 5.81 | 5.89 | 4.10 | 9.21 |
P | 0.0003 | 0.0003 | 0.0041 | 0.000 |
R-squared | 0.205 | 0.215 | 0.146 | 0.375 |
*p<0.1,
** p<0.05,
*** p<0.01;
HY III was used as reference category in Model 4; t-statistics in parentheses.